Sofinnova Partners Secures €1.2 Billion for Life Sciences Innovation

Sofinnova Partners raised €1.2 billion across its investment strategies over the past year, with over €1 billion secured in the last quarter alone146.

The firm plans to support 50 to 60 new companies across seven investment strategies, ranging from incubation to later-stage growth146.

Sofinnova's investment focus spans biotech, medtech, industrial biotechnology, and digital medicine126.

The new funding brings Sofinnova's total assets under management to more than €4 billion26.

Sofinnova has a team of over 80 professionals, including 25 investment partners, spread across offices in Paris, London, and Milan16.

The firm has launched Sofinnova.ai, an AI-powered platform to enhance its investment process26.

Founded in 1972, Sofinnova Partners has backed over 500 companies in its 50-year history46.

The funds have attracted significant commitments from institutional investors, sovereign wealth funds, corporates, and family offices46.

Sofinnova aims to empower entrepreneurs tackling pressing health and sustainability challenges146.

The firm has doubled its assets under management in the last five years6.

Sources:

1. https://www.fiercebiotech.com/biotech/vc-firm-sofinnova-brings-16b-euros-over-year-fund-60-life-sciences-companies

2. https://med-tech.world/news/sofinnova-partners-secures-e1-2-billion-to-drive-life-sciences-innovation/

4. http://www.afp.com/en/infos/sofinnova-partners-raises-eu12-billion-fuel-next-wave-life-sciences-innovation

6. https://sofinnovapartners.com/news/sofinnova-partners-raises-eur1-2-billion-to-fuel-the-next-wave-of-life-sciences-innovation